Medicines Valuation Percentage
Medicines Valuation Percentage Chart
View Valuation Percentage for MDCO.
Start Your YCharts Pro Gold Membership.
Medicines Historical Valuation Percentage Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | Go Pro |
| March 31, 2013 | Go Pro |
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
| June 30, 2009 | Go Pro |
| March 31, 2009 | Go Pro |
| Dec. 31, 2008 | Go Pro |
| Sept. 30, 2008 | Go Pro |
| June 30, 2008 | Go Pro |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
View Valuation Percentage for MDCO.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
MDCO Valuation Percentage Benchmarks
| Companies | |
|---|---|
| Ligand Pharmaceuticals | Go Pro |
| Bristol-Myers Squibb | Go Pro |
| Actavis | Go Pro |
MDCO Valuation Percentage Rankings
| Overall |
57th percentile 3388 of 8002 |
| Sector |
52nd percentile 322 of 684 in Healthcare |
| Industry |
60th percentile 27 of 68 in Drug Manufacturers - Specialty & Generic |
MDCO Valuation Percentage Range, Past 5 Years
| Minimum | Go Pro | Sep 2012 |
| Maximum | Go Pro | Dec 2009 |
| Average | Go Pro |
